Expression of heterologous CD59 and CRRY protects human breast cancer cells from anti-MUC-1 directed complement-mediated lysis

被引：1
|
作者：
Caragine, T
Chen, S
Frey, A
Tomlinson, S
机构：
[1] NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA
[2] NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA
来源：
MOLECULAR IMMUNOLOGY | 1998年 / 35卷 / 6-7期
关键词：
D O I：
10.1016/S0161-5890(98)90560-0
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
28
引用
收藏
页码：337 / 337
页数：1
相关论文
共 50 条
  • [31] THE EXPRESSION OF THE COMPLEMENT REGULATORS CD46, CD55, AND CD59 BY HUMAN SPERM DOES NOT PROTECT THEM FROM ANTISPERM ANTIBODY-MEDIATED AND COMPLEMENT-MEDIATED IMMUNE INJURY
    DCRUZ, OJ
    HAAS, GG
    [J]. FERTILITY AND STERILITY, 1993, 59 (04) : 876 - 884
  • [32] Downregulation of miRNA-26a by HIV-1 Enhances CD59 Expression and Packaging, Impacting Virus Susceptibility to Antibody-Dependent Complement-Mediated Lysis
    Bellini, Nicolas
    Ye, Chengyu
    Ajibola, Oluwaseun
    Murooka, Thomas T.
    Lodge, Robert
    Cohen, eric A.
    [J]. VIRUSES-BASEL, 2024, 16 (07):
  • [33] PHYSIOLOGICAL RELEVANCE OF THE MEMBRANE ATTACK COMPLEX INHIBITORY PROTEIN CD59 IN HUMAN SEMINAL PLASMA - CD59 IS PRESENT ON EXTRACELLULAR ORGANELLES (PROSTASOMES), BINDS CELL-MEMBRANES, AND INHIBITS COMPLEMENT-MEDIATED LYSIS
    ROONEY, IA
    ATKINSON, JP
    KRUL, ES
    SCHONFELD, G
    POLAKOSKI, K
    SAFFITZ, JE
    MORGAN, BP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (05): : 1409 - 1420
  • [34] CD55 and CD59 expression protects HER2-overexpressing breast cancer cells from trastuzumab-induced complement-dependent cytotoxicity
    Wang, Yu
    Yang, Ya-Jun
    Wang, Zhu
    Liao, Juan
    Liu, Mei
    Zhong, Xiao-Rong
    Zheng, Hong
    Wang, Yan-Ping
    [J]. ONCOLOGY LETTERS, 2017, 14 (03) : 2961 - 2969
  • [35] CRISPR DELETION OF NLRP3 IN SYNOVIOCYTES RENDERS CELLS RESISTANT TO COMPLEMENT-MEDIATED INJURY AND DEATH BY INCREASING SURFACE EXPRESSION OF CD59
    Walters, David
    Gormley, Darren
    Triantafilou, Kathy
    Nichols, Eva-Maria
    Hynes, Roanne
    Olden, Robin
    Hughes, Timothy
    Morgan, Bryan Paul
    [J]. MOLECULAR IMMUNOLOGY, 2019, 114 : 459 - 459
  • [36] Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody
    Akewanlop, C
    Watanabe, M
    Singh, B
    Walker, M
    Kufe, DW
    Hayes, DF
    [J]. CANCER RESEARCH, 2001, 61 (10) : 4061 - 4065
  • [37] ANTIBODY-DEPENDENT COMPLEMENT-MEDIATED CYTOTOXICITY IN SERA FROM PATIENTS WITH HIV-1 INFECTION IS CONTROLLED BY CD55 AND CD59
    SCHMITZ, J
    ZIMMER, JP
    KLUXEN, B
    ARIES, S
    BOGEL, M
    GIGLI, I
    SCHMITZ, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03): : 1520 - 1526
  • [38] A high affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: Implications for treatment of HIV-1/AIDS
    Hu, Weiguo
    Yu, Qigui
    Hu, Ningjie
    Byrd, Daniel
    Amet, Tohti
    Shikuma, Cecilia
    Shiramizu, Bruce
    Halperin, Jose A.
    Qin, Xuebin
    [J]. MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2250 - 2250
  • [39] Specific targeting of anti-CD59 siRNA by Herceptin®-conjugated liposomes improves complement-mediated cytotoxicity of breast carcinoma cells
    Li, W.
    Geis, N.
    Kirschfink, M.
    [J]. MOLECULAR IMMUNOLOGY, 2009, 46 (14) : 2830 - 2831
  • [40] PROTECTION OF HUMAN AMNIOTIC EPITHELIAL-CELLS (HAEC) FROM COMPLEMENT-MEDIATED LYSIS - EXPRESSION ON THE CELLS OF 3 COMPLEMENT INHIBITORY MEMBRANE-PROTEINS
    ROONEY, IA
    MORGAN, BP
    [J]. IMMUNOLOGY, 1990, 71 (03) : 308 - 311
12345